Literature DB >> 1238506

Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

N F Pierce, J L Gowans.   

Abstract

The aims of this study were (a) to find a regime of immunization with cholera toxoid in rats which would establish a high density of antitoxin containing cells (ACC) in the lamina propria of the intestine and (b) to determine the origin of the ACC. The best cellular response was achieved by a single i.p. dose of toxoid in FCA followed by an intraintestinal boost 2 wk later. ACC appeared in the thoracic duct lymph 2 days after boosting, reaching a peak of about 200,000 ACC/h at 3--4 days. This was followed by the appearance of large numbers of ACC in the intestine. The i.p. dose of toxoid by itself gave rise to very few ACC in the gut or thoracic duct lymph, but it had clearly primed the gut immune system for a secondary response. Priming was also achieved by the prolonged oral intake of toxoid. The importance of the intestinal route for boosting was shown by the failure of i.p. challenge to give an ACC response in the intestine after i.p. priming and the small response it provoked after oral priming. ACC among thoracic duct lymphocytes (TDL) and in the lamina propria contained predominantly IgA. Two observations indicated that the major source of the lamina propria ACC was from cells that emerged in the thoracic duct lymph after intraintestinal challenge. Firstly, the establishment of a thoracic duct fistula immediately before challenge prevented the appearance of ACC in the intestine. Secondly, many ACC appeared in the intestine of normal rats after the injection of TDL rich in ACC. Although homing of ACC precursors to the gut was not antigen-dependent, the distribution of ACC in the lamina propria was considerably influenced by the site of the intestinal challenge, the density of ACC being greatest at or distal to the site of injection of toxoid into the lumen of the gut.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1238506      PMCID: PMC2190063          DOI: 10.1084/jem.142.6.1550

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  The lymph-borne cells of the immune response.

Authors:  J G HALL; B MORRIS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1963-07

2.  The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes.

Authors:  J C Jensenius; A F Williams
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

3.  Peyer's patches: lack of specific antibody-containing cells after oral and parenteral immunization.

Authors:  J Bienenstock; J Dolezel
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

4.  The homing of lymph-borne immunoblasts to the small gut of neonatal rats.

Authors:  T E Halstead; J G Hall
Journal:  Transplantation       Date:  1972-09       Impact factor: 4.939

5.  Cutaneous responses to cholera skin toxin in man. I. Responses in unimmunized American males.

Authors:  J P Craig; E R Eichner; R B Hornick
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

6.  The distribution and differentiation of lymph-borne immunoblasts after intravenous injection into syngeneic recipients.

Authors:  J G Hall; D M Parry; M E Smith
Journal:  Cell Tissue Kinet       Date:  1972-05

7.  Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation.

Authors:  T H The; T E Feltkamp
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

8.  The gut-associated lymphoid system: nature and properties of the large dividing cells.

Authors:  D Guy-Grand; C Griscelli; P Vassalli
Journal:  Eur J Immunol       Date:  1974-06       Impact factor: 5.532

9.  Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.

Authors:  H D Hochstein; J C Feeley; W E DeWitt
Journal:  Appl Microbiol       Date:  1970-05

10.  The presence of IgA on the surface of rat thoractic duct lymphocytes which contain internal IgA.

Authors:  A F Williams; J L Gowans
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  101 in total

1.  Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains.

Authors:  A Hohmann; G Schmidt; D Rowley
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions.

Authors:  C P Kelly; C F Feighery; R B Gallagher; M J Gibney; D G Weir
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 3.  Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria.

Authors:  Andrew J Macpherson; Markus B Geuking; Kathy D McCoy
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

4.  Defence of mucous membranes by antibodies, receptor analogues and non-specific host factors.

Authors:  L A Hanson; B Andersson; B Carlsson; U Dahlgren; L Mellander; O Porras; T Söderström; C Svanborg Edén
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Immunological cross-reactivity of enterotoxins of Aeromonas hydrophila and cholera toxin.

Authors:  C James; M Dibley; V Burke; J Robinson; M Gracey
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

6.  T lymphocytes in the intestinal epithelium and lamina propria of mice.

Authors:  M R McDermott; P Horsewood; D A Clark; J Bienenstock
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

7.  Studies on the adjuvant action of beryllium. II. Systemic effects with particular reference to secretory immunity.

Authors:  J G Hall; J Spencer
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

8.  Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.

Authors:  C Lue; A W van den Wall Bake; S J Prince; B A Julian; M L Tseng; J Radl; C O Elson; J Mestecky
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Role of Peyer's patch in the intestinal immune response to cholera toxin in enterically immunized rats.

Authors:  G A Enders; M Delius; S Ballhaus; W Brendel
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes.

Authors:  N F Pierce; J B Sacci
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.